STAT+: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter

<iframe
  src="https://statesidedaily.com/embed/cluster/24070afc3829169900c3f7a3395c788ac679849d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Under a new leader, the FDA&#8217;s biologics center moves to steady itself after stormy chapter"></iframe>